Vertex Pharmaceuticals Inc. buy Scotiabank
Start price
14.11.25
/
50%
€377.95
Target price
14.11.26
-
Performance (%)
6.64%
Price
17:16
€403.05
Summary
This prediction is currently active. The BUY prediction by Scotiabank shows slight gains of 6.64%. This prediction currently runs until 14.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 6.051% | 6.051% |
| iShares Core DAX® | -0.121% | 2.507% |
| iShares Nasdaq 100 | 0.081% | -0.241% |
| iShares Nikkei 225® | -1.748% | 4.105% |
| iShares S&P 500 | -0.961% | -0.143% |
Comments by Scotiabank for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for VRTX provided by MarketBeat